Precision Antibopdy

Precision Antibody is a biotechnology company that provides custom antibody development and production services, including monoclonal and polyclonal antibodies, antibody humanization, and epitope mapping. Founded in 2000 and based in Columbia, Maryland, the company utilizes proprietary technologies such as Total Epitope Display (TED), Smart Fusion, and specialized immunization protocols to accelerate antibody generation. Their platform allows for the delivery of high-affinity antibodies in as little as 30 to 60 days. The firm operates as a wholly owned division of A&G Pharmaceutical, Inc. and maintains AAALAC and OLAW-accredited laboratory facilities to support its research and production workflows.

By offering rapid, reliable, and application-specific antibody solutions, Precision Antibody serves pharmaceutical companies, biotechnology firms, academic research centers, and federal laboratories worldwide. Their services address critical challenges in therapeutic antibody discovery, diagnostic development, and preclinical research by focusing on target-specific performance and functional reliability. With a reported success rate exceeding 95%, the company assists clients across diverse sectors including oncology, medicine, and food safety, helping to shorten development timelines for therapeutic products and drug conjugates. Their collaborative approach emphasizes tailoring antibody strategies to the unique requirements of the customer's intended assay and target biology.